Francis Lidgey
Direktor/Vorstandsmitglied bei Phibex Plc
Profil
Francis John Lidgey is currently a Director at Phibex Plc and a Professor-Emeritus at Oxford Brookes University since 1992.
He previously held positions as Non-Executive Chairman at Levrett Plc, Non-Executive Director at Nuformix Technologies Ltd., Independent Non-Executive Director at Nuformix Plc, and Director at LTP Electronics Ltd.
Lidgey earned doctorate degrees from The University of Newcastle in 1977 and the University of Surrey in 1973.
Aktive Positionen von Francis Lidgey
| Unternehmen | Position | Beginn |
|---|---|---|
| Oxford Brookes University | Corporate Officer/Principal | 01.01.1992 |
| Phibex Plc | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Francis Lidgey
| Unternehmen | Position | Ende |
|---|---|---|
| NUFORMIX PLC | Direktor/Vorstandsmitglied | 31.01.2020 |
| LTP Electronics Ltd. | Direktor/Vorstandsmitglied | - |
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Levrett Plc
 Levrett Plc BiotechnologyHealth Technology Levrett Plc is a special purpose acquisition company. It is formed to acquire realizable and/or developed commercial technologies focused in the pharmaceutical and biotechnology sector. The company was founded on June 10, 2015 and is headquartered in London, the United Kingdom. | Vorsitzender | - |
Ausbildung von Francis Lidgey
| The University of Newcastle | Doctorate Degree |
| University of Surrey | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NUFORMIX PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Levrett Plc
Levrett Plc BiotechnologyHealth Technology Levrett Plc is a special purpose acquisition company. It is formed to acquire realizable and/or developed commercial technologies focused in the pharmaceutical and biotechnology sector. The company was founded on June 10, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
| Phibex Plc | |
| LTP Electronics Ltd. |